Daily cannabis news
po.tc tracks the practical cannabis stories that shape operators, investors, regulators, and suppliers: medical access, licensing, imports, tax exposure, retail structure, and the policy decisions behind them.
Latest articles
A new analysis of Australian Health Department data says medicinal-cannabis units sold fell 28.5 percent in the second half of 2025, suggesting tougher scrutiny of prescribing, supply and advertising is already cutting into one of the world’s fastest-growing medical markets.
Read moreIreland has started a formal review of medical cannabis access just as new parliamentary reporting shows the state programme has approved only 74 patients, underscoring how little legal demand the current system is capturing.
Read moreNew Oklahoma data show the average dispensary is now splitting a larger share of a still-shrinking medical cannabis market, just months before the state’s license moratorium is due to expire.
Read moreNews feed
Australia’s medicinal-cannabis market has printed its first clear reverse. Penington Institute said in an April 2026 analysis that units sold fell to 2.65 million in the second half of 2025, down from 3.70 million in the first...
Read moreIreland has moved from talking about medical cannabis reform to formally reviewing it. On 1 April, the Department of Health announced the appointment of a chair to lead a review of access to cannabis for medical use. That...
Read moreOklahoma’s retail cannabis market is still smaller than it was a year ago. But the average dispensary is finally carrying more volume.
Read moreVirginia has stopped talking about a retail cannabis market in the abstract and started pricing it. Budget language tied to the retail-market push provides $18,223,509 for fiscal year 2027 and $22,221,363 for fiscal year 2028 for...
Read moreNew York has stopped allowing cannabis retailers to file inventory and sales reports manually. The state Office of Cannabis Management said the manual system ended on May 5, 2026, and that all inventory and sales transactions...
Read moreBrazil’s first federal framework for medicinal-cannabis production is no longer a policy headline. It is an implementation deadline.
Read moreSpain now has a visible upstream medical-cannabis market.
Read more